Language Select
Varian Logo

Press Releases

June 07, 2019
Varian (NYSE: VAR) today announced it will be hosting its second FlashForward™ Consortium meeting at 12:00pm Tuesday, June 11th at the 58th annual Particle Therapy Co-Operative Group meeting... Read more
June 06, 2019
Varian (NYSE: VAR) announced it will be showcasing its new ProBeam® 360° proton therapy system*, June 12th-15th in Manchester, United Kingdom at the 58th PTCOG Conference (Particle Therapy... Read more
May 29, 2019
Varian (NYSE: VAR) today announced it will be showcasing its Noona® patient management system and its 360 Oncology™ care management platform, May 31-June 4 in Chicago, Illinois at the 2019 ASCO... Read more
May 28, 2019
Varian (NYSE: VAR) today announced a physicist using Varian's Eclipse™ treatment planning system achieved the top overall score in the TROG 2019 Stereotactic Body Radiation Therapy (SBRT)... Read more
May 20, 2019
Taking an important step to accelerate innovation of new multidisciplinary solutions to address the growing global cancer burden, Varian Medical Systems (NYSE: VAR) today announced it has entered... Read more
May 16, 2019
Varian (NYSE: VAR) today announced preliminary estimates of the incremental gross impact of new tariffs. Over the past week, the US increased tariffs on certain goods (US List 3), and imposed new... Read more
May 13, 2019
At a ceremony in Singapore today, Varian (NYSE: VAR) announced, in partnership with Proton Therapy Pte., Ltd, the completion of the cyclotron installation for the Varian ProBeam® Compact... Read more
May 13, 2019
Varian (NYSE: VAR) today announced it was selected by Port Moresby General Hospital (PMGH) in Papua New Guinea to equip its cancer treatment center with the Halcyon™ radiotherapy system, as well... Read more
May 09, 2019
Acquisition Key Highlights The CyberHeart acquisition secures significant intellectual property/patents that cover the use of radiation in the heart. Early positive clinical evidence suggests that... Read more
May 09, 2019
Following a comprehensive evaluation by Sykehusbygg HF Norway and regional health authorities, Varian (NYSE: VAR) was selected to equip two proton therapy centers in Norway with the ProBeam®... Read more

Corporate Communications Contact

Mark Plungy
Director, Public Relations

Investor Relations Contact

Mike Bruff
SVP, Investor Relations